Last updated 2026-07-20
- Raised $300M Series D led by Patient Square Capital, May 2022
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Enavate Sciences is a platform dedicated to supporting therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient needs. They provide capital support and operational experience to empower a diverse portfolio of therapeutics companies to accelerate innovation.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Enavate Sciences' investment focus?
- Enavate Sciences supports therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient needs.
- Which sectors does Enavate Sciences primarily invest in?
- Enavate Sciences has a primary focus on the Health Tech & Life Sciences sector.
- Has Enavate Sciences made any recent investments?
- Yes, Enavate Sciences participated in a B Round for Upstream Bio in June 2023.
- What is a notable portfolio company for Enavate Sciences?
- Upstream Bio, a company developing a monoclonal antibody drug for asthma patients, is a notable portfolio company for Enavate Sciences.
- What was the size of the funding round for Upstream Bio that Enavate Sciences participated in?
- Enavate Sciences participated in a B Round for Upstream Bio, which raised $400M.
- What stage investments does Enavate Sciences typically make?
- Enavate Sciences has participated in B Round investments, such as their investment in Upstream Bio.
- What is Enavate Sciences' typical investment range?
- Enavate Sciences' investment range is $200M - $200M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2022-5 |
|---|